NASDAQ

RF Acquisition Corp II - Unit (RFAIU)

497 Thanks from members

Web sentiment and market intelligence for RF Acquisition Corp II - Unit (RFAIU) show intense bullish momentum following the August 19, 2026, shareholder approval of the Nanyang Biologics merger, driving unit and common share prices up over 200% to 360%+ to test highs near $51.76–$58.00.

No chart available for this instrument.
Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →